# Bactolife A/S: Not applicable (device, behavioral) study in Gut Health, Gastrointestinal Symptoms (800 participants)

**Score:** 50/100

| Field | Value |
|---|---|
| Sponsor | Bactolife A/S |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | IgG Binding Protein LT in Support of a Healthy Gut on the Go |
| NCT ID | NCT07873957 |
| Phase | Not applicable (device, behavioral) |
| Status | recruiting |
| Conditions | Gut Health; Gastrointestinal Symptoms; Safety in Healthy Adults |
| Intervention types | dietary supplement |
| Target enrollment | 800 |
| Site countries | United States |
| Posted | 2026-10-14 |
| Planned start | 2026-10-12 |
| Event | Newly registered study |
| Event date | 2026-10-14 |

## Why this score
- Industry sponsor (buys outsourced services).
- 800 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07873957). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.